“…A weak activity of M. oppositifolius isolates was recorded on yeasts with inhibition zone diameters between 10 and 18 mm compared to the reference drug (amphotericin B, 21-23 mm). Nevertheless, the elicited activity could be inherently attributed to the presence of antimicrobial secondary metabolites such as phenols, tannins, flavonoids, alkaloids, glycosides, anthraquinones, terpenoids and essential oils previously reported in M. oppositifolius (Gbedema et al, 2010;Herborne, 1976;Okwu and Okwu, 2004) either on an individual scale, or to their concerted contributions (Cowan, 1999;Latte and Kolodziej, 2000;Modafar et al, 2000;Charrouf and Guillaume, 2002). C. albicans was less susceptible than C. krusei to fraction G. Indeed, M. oppositifolius extracts previously showed varying degrees of in vitro antifungal activity against yeasts (Adekunle and Ikumapayi, 2006;Mosango, 2007).…”